A new model of pneumococcal lipoteichoic acid structure resolves biochemical, biosynthetic, and serologic inconsistencies of the current model

Journal of Bacteriology

Volumn 190, Issue 7, 2008, Pages 2379-2387

  Ho, Seong Seo ^a,b   Cartee, Robert T ^b   Pritchard, David G ^c   Nahm, Moon H ^a,b  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORSSMAN ANTIGEN; HYDROFLUORIC ACID; LIPID; LIPOTEICHOIC ACID; N ACETYLGALACTOSAMINE; NITROUS ACID; POLYSACCHARIDE; RIBITOL;

ANTIGEN STRUCTURE; ARTICLE; BACTERIAL CELL WALL; BACTERIAL STRAIN; BACTERIUM ISOLATE; CELL ULTRASTRUCTURE; MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; PREDICTION; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

ANTIGENS, BACTERIAL; CARBOHYDRATE SEQUENCE; HYDROFLUORIC ACID; LIPOPOLYSACCHARIDES; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; SODIUM NITRITE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STREPTOCOCCUS PNEUMONIAE; TANDEM MASS SPECTROMETRY; TEICHOIC ACIDS;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS PNEUMONIAE;

EID: 41549141383     PISSN: 00219193     EISSN: None     Source Type: Journal    
DOI: 10.1128/JB.01795-07     Document Type: Article

References (53)

1. Abachin, E., C. Poyart, E. Pellegrini, E. Milohanic, F. Fiedler, P. Berche, and P. Trieu-Cuot. 2002. Formation of D-alanyl-lipoteichoic acid is required for adhesion and virulence of Listeria monocytogenes. Mol. Microbiol. 43:1-14.
2. Beachey, E. H., and W. A. Simpson. 1982. The adherence of group A streptococci to oropharyngeal cells: the lipoteichoic acid adhesin and fibronectin receptor. Infection 10:107-111.
3. Behr, T., W. Fischer, J. Peter-Katalinic, and H. Egge. 1992. The structure of pneumococcal lipoteichoic acid. Improved preparation, chemical and mass spectrometric studies. Eur. J. Biochem. 207:1063-1075.
4. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
5. Briles, D. E., M. Nahm, K. Schroer, J. Davie, P. Baker, J. Kearney, and R. Barletta. 1981. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae. J. Exp. Med. 153:694-705.
6. Brundish, D. E., N. Shaw, and J. Baddiley. 1967. The phospholipids of Pneumococcus I-192R, A.T.C.C. 12213. Some structural rearrangements occurring under mild conditions. Biochem. J. 104:205-211.
7. Carruthers, M. M., and W. J. Kabat. 1983. Mediation of staphylococcal adherence to mucosal cells by lipoteichoic acid. Infect. Immun. 40:444-446.
8. Chan, K. G., M. Mayer, E. M. Davis, S. A. Halperin, T. J. Lin, and S. F. Lee. 2007. Role of D-alanylation of Streptococcus gordonii lipoteichoic acid in innate and adaptive immunity. Infect. Immun. 75:3033-3042.
9. Chugh, T. D., G. J. Burns, H. J. Shuhaiber, and G. M. Bahr. 1990. Adherence of Staphylococcus epidermidis to fibrin-platelet clots in vitro mediated by lipoteichoic acid. Infect. Immun. 58:315-319.
10. Coyne, M. J., A. O. Tzianabos, B. C. Mallory, V. J. Carey, D. L. Kasper, and L. E. Comstock. 2001. Polysaccharide biosynthesis locus required for virulence of Bacteroides fragilis. Infect. Immun. 69:4342-4350.
11. Draing, C., M. Pfitzenmaier, S. Zummo, G. Mancuso, A. Geyer, T. Hartung, and S. von Aulock. 2006. Comparison of lipoteichoic acid from different serotypes of Streptococcus pneumoniae. J. Biol. Chem. 281:33849-33859.
12. Ellingsen, E., S. Morath, T. Flo, A. Schramm, T. Hartung, C. Thiemermann, T. Espevik, D. Golenbock, D. Foster, R. Solberg, A. Aasen, and J. Wang. 2002. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14. Med. Sci. Monit. 8:BR149-BR156.
13. Fischer, W. 1988. Physiology of lipoteichoic acids in bacteria. Adv. Microb. Physiol. 29:233-302.
14. Fischer, W. 2000. Pneumococcal lipoteichoic and teichoic acid, p. 155-177. In A. Tomasz (ed.), Streptococcus pneumoniae molecular biology and mechanisms of disease. Mary Ann Liebert, Inc., New York, NY.
15. Fischer, W., T. Behr, R. Hartmann, J. Peter-Katalinic, and H. Egge. 1993. Teichoic acid and lipoteichoic acid of Streptococcus pneumoniae possess identical chain structures. A reinvestigation of teichoid acid (C polysaccharide). Eur. J. Biochem. 215:851-857.
16. Fuchs, B., C. Schober, G. Richter, R. Suss, and J. Schiller. 2007. MALDITOF MS of phosphatidylethanolamines: different adducts cause different post source decay (PSD) fragment ion spectra. J. Biochem. Biophys. Methods 70:689-692.
17. Grundling, A., and O. Schneewind. 2007. Genes required for glycolipid synthesis and lipoteichoic acid anchoring in Staphylococcus aureus. J. Bacteriol. 189:2521-2530.
18. Grundling, A., and O. Schneewind. 2007. Synthesis of glycerol phosphate lipoteichoic acid in Staphylococcus aureus. Proc. Natl. Acad. Sci. USA 104: 8478-8483.
19. Han, S. H., J. H. Kim, M. Martin, S. M. Michalek, and M. H. Nahm. 2003. Pneumococcal lipoteichoic acid (LTA) is not as potent as staphylococcal LTA in stimulating Toll-like receptor 2. Infect. Immun. 71:5541-5548.
20. Heissigerova, H., C. Breton, J. Moravcova, and A. Imberty. 2003. Molecular modeling of glycosyltransferases involved in the biosynthesis of blood group A, blood group B, Forssman, and iGb3 antigens and their interaction with substrates. Glycobiology 13:377-386.
21. Hoebe, K., P. Georgel, S. Rutschmann, X. Du, S. Mudd, K. Crozat, S. Sovath, L. Shamel, T. Hartung, U. Zahringer, and B. Beutler. 2005. CD36 is a sensor of diacylglycerides. Nature 433:523-527.
22. Holtje, J. V., and A. Tomasz. 1975. Lipoteichoic acid: a specific inhibitor of autolysin activity in Pneumococcus. Proc. Natl. Acad. Sci. USA 72:1690-1694.
23. Hoskins, J., W. E. Alborn, Jr., J. Arnold, L. C. Blaszczak, S. Burgett, B. S. DeHoff, S. T. Estrem, L. Fritz, D. J. Fu, W. Fuller, C. Geringer, R. Gilmour, J. S. Glass, H. Khoja, A. R. Kraft, R. E. Lagace, D. J. LeBlanc, L. N. Lee, E. J. Lefkowitz, J. Lu, P. Matsushima, S. M. McAhren, M. McHenney, K. McLeaster, C. W. Mundy, T. I. Nicas, F. H. Norris, M. O'Gara, R. B. Peery, G. T. Robertson, P. Rockey, P. M. Sun, M. E. Winkler, Y. Yang, M. Young-Bellido, G. Zhao, C. A. Zook, R. H. Baltz, S. R. Jaskunas, P. R. Rosteck, Jr., P. L. Skatrud, and J. I. Glass. 2001. Genome of the bacterium Streptococcus pneumoniae strain R6. J. Bacteriol. 183:5709-5717.
24. Hummell, D. S., A. J. Swift, A. Tomasz, and J. A. Winkelstein. 1985. Activation of the alternative complement pathway by pneumococcal lipoteichoic acid. Infect. Immun. 47:384-387.
25. Iannelli, F., B. J. Pearce, and G. Pozzi. 1999. The type 2 capsule locus of Streptococcus pneumoniae. J. Bacteriol. 181:2652-2654.
26. Jennings, H. J., C. Lugowski, and N. M. Young. 1980. Structure of the complex polysaccharide C-substance from Streptococcus pneumoniae type 1. Biochemistry 19:4712-4719.
27. Kaufman, B., D. Kundig, J. Distler, and S. Roseman. 1965. Enzymatic synthesis and structure of two glycolipids from type XIV Pneumococcus. Biochem. Biophys. Res. Commun. 18:312-318.
28. Kharat, A. S., and A. Tomasz. 2006. Drastic reduction in the virulence of Streptococcus pneumoniae expressing type 2 capsular polysaccharide but lacking choline residues in the cell wall. Mol. Microbiol. 60:93-107.
29. Kim, J. H., H. Seo, S. H. Han, J. Lin, M. K. Park, U. B. Sorensen, and M. H. Nahm. 2005. Monoacyl lipoteichoic acid from pneumococci stimulates human cells but not mouse cells. Infect. Immun. 73:834-840.
30. Kiriukhin, M. Y., D. V. Debabov, D. L. Shinabarger, and F. C. Neuhaus. 2001. Biosynthesis of the glycolipid anchor in lipoteichoic acid of Staphylococcus aureus RN4220: role of YpfP, the diglucosyldiacylglycerol synthase. J. Bacteriol. 183:3506-3514.
31. Kovacs, M., A. Halfmann, I. Fedtke, M. Heintz, A. Peschel, W. Vollmer, R. Hakenbeck, and R. Bruckner. 2006. A functional dlt operon, encoding proteins required for incorporation of D-alanine in teichoic acids in gram-positive bacteria, confers resistance to cationic antimicrobial peptides in Streptococcus pneumoniae. J. Bacteriol. 188:5797-5805.
32. Kristian, S. A., V. Datta, C. Weidenmaier, R. Kansal, I. Fedtke, A. Peschel, R. L. Gallo, and V. Nizet. 2005. D-Alanylation of teichoic acids promotes group a streptococcus antimicrobial peptide resistance, neutrophil survival, and epithelial cell invasion. J. Bacteriol. 187:6719-6725.
33. Lanie, J. A., W. L. Ng, K. M. Kazmierczak, T. M. Andrzejewski, T. M. Davidsen, K. J. Wayne, H. Tettelin, J. I. Glass, and M. E. Winkler. 2007. Genome sequence of Avery's virulent serotype 2 strain D39 of Streptococcus pneumoniae and comparison with that of unencapsulated laboratory strain R6. J. Bacteriol. 189:38-51.
34. Lindberg, B., B. Lindqvist, J. Lonngren, and D. A. Powell. 1980. Structural studies of the capsular polysaccharide from Streptococcus pneumoniae type 1. Carbohydr. Res. 78:111-117.
35. Lovett, E. G., and D. Lipkin. 1977. Base-catalyzed reactions of 1,3-disubstituted uracils. J. Org. Chem. 42:2574-2580.
36. Lubick, K., and M. A. Jutila. 2006. LTA recognition by bovine γδ T cells involves CD36. J. Leukoc Biol. 79:1268-1270.
37. Neuhaus, F. C., R. Linzer, and V. M. Reusch, Jr. 1974. Biosynthesis of membrane teichoic acid: role of the D-alanine- activating enzyme and D-alanine: membrane acceptor ligase. Ann. N. Y. Acad. Sci. 235:502-518.
38. Qian, Z., Y. Yin, Y. Zhang, L. Lu, Y. Li, and Y. Jiang. 2006. Genomic characterization of ribitol teichoic acid synthesis in Staphylococcus aureus: genes, genomic organization and gene duplication. BMC Genomics 7:74.
39. Raisanen, L., C. Draing, M. Pfitzenmaier, K. Schubert, T. Jaakonsaari, S. von Aulock, T. Hartung, and T. Alatossava. 2007. Molecular interaction between lipoteichoic acids and Lactobacillus delbrueckii phages depends on D-alanyl and alpha-glucose substitution of poly(glycerophosphate) backbones. J. Bacteriol. 189:4135-4140.
40. Schiller, J., J. Arnhold, S. Benard, M. Muller, S. Reichl, and K. Arnold. 1999. Lipid analysis by matrix-assisted laser desorption and ionization mass spectrometry: a methodological approach. Anal. Biochem. 267:46-56.
41. Schwandner, R., R. Dziarski, H. Wesche, M. Rothe, and C. J. Kirschning. 1999. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J. Biol. Chem. 274:17406-17409.
42. Seo, H. S., J. H. Kim, and M. H. Nahm. 2006. Platelet-activating factor-acetylhydrolase can monodeacylate and inactivate lipoteichoic acid. Clin. Vaccine Immunol. 13:452-458.
43. Severin, A., and A. Tomasz. 2000. The peptidoglycan of Streptococcus pneumoniae, p. 179-195. In A. Tomasz (ed.), Streptococcus pneumoniae: molecular biology and mechanisms of disease. Mary Ann Liebert, Inc., New York, NY.
44. Tettelin, H., K. E. Nelson, I. T. Paulsen, J. A. Eisen, T. D. Read, S. Peterson, J. Heidelberg, R. T. DeBoy, D. H. Haft, R. J. Dodson, A. S. Durkin, M. Gwinn, J. F. Kolonay, W. C. Nelson, J. D. Peterson, L. A. Umayam, O. White, S. L. Salzberg, M. R. Lewis, D. Radune, E. Holtzapple, H. Khouri, A. M. Wolf, T. R. Utterback, C. L. Hansen, L. A. McDonald, T. V. Feldblyum, S. Angiuoli, T. Dickinson, E. K. Hickey, I. E. Holt, B. J. Loftus, F. Yang, H. O. Smith, J. C. Venter, B. A. Dougherty, D. A. Morrison, S. K. Hollingshead, and C. M. Fraser. 2001. Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science 293:498-506.
45. Thanassi, J. A., S. L. Hartman-Neumann, T. J. Dougherty, B. A. Dougherty, and M. J. Pucci. 2002. Identification of 113 conserved essential genes using a high-throughput gene disruption system in Streptococcus pneumoniae. Nucleic Acids Res. 30:3152-3162.
46. Theilacker, C., Z. Kaczynski, A. Kropec, F. Fabretti, T. Sange, O. Holst, and J. Huebner. 2006. Opsonic antibodies to Enterococcus faecalis strain 12030 are directed against lipoteichoic acid. Infect. Immun. 74:5703-5712.
47. Vialle, S., P. Sepulcri, J. Dubayle, and P. Talaga. 2005. The teichoic acid (C-polysaccharide) synthesized by Streptococcus pneumoniae serotype 5 has a specific structure. Carbohydr. Res. 340:91-96.
48. Vollmer, W., and A. Tomasz. 2001. Identification of the teichoic acid phosphorylcholine esterase in Streptococcus pneumoniae. Mol. Microbiol. 39: 1610-1622.
49. Walsh, S., J. Kokai-Kun, A. Shah, and J. Mond. 2004. Extended nasal residence time of lysostaphin and an anti-staphylococcal monoclonal antibody by delivery in semisolid or polymeric carriers. Pharm. Res. 21:1770-1775.
50. Weidenmaier, C., A. Peschel, V. A. Kempf, N. Lucindo, M. R. Yeaman, and A. S. Bayer. 2005. DltABCD- and MprF-mediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model. Infect. Immun. 73:8033-8038.
51. Weisman, L. E., R. F. Schuman, E. Lukomska, J. R. Stinson, O. Parks, and G. W. Fischer. 2001. Effectiveness and pharmacokinetics of an anti-lipoteichoic acid humanized mouse chimeric monoclonal antibody. Pediatr. Res. 49:301A.
52. Yother, J. 2004. Capsules, p. 30-48. In E. I. Tuomanen, T. J. Mitchell, D. A. Morrison, and B. G. Spratt (ed.), The Pneumococcus. ASM Press, Washington, DC.
53. Zhang, J. R., I. Idanpaan-Heikkila, W. Fischer, and E. I. Tuomanen. 1999. Pneumococcal licD2 gene is involved in phosphorylcholine metabolism. Mol. Microbiol. 31:1477-1488.